PMID: 15338800Sep 2, 2004Paper

Prospective evaluation of pneumonia severity index in hospitalised patients with community-acquired pneumonia

Respiratory Medicine
M M van der EerdenW G Boersma

Abstract

The aim of the present study was to investigate whether the pneumonia severity index (PSI) could adequately predict the severity of community-acquired pneumonia (CAP) and could be used as a severity of illness classification system. Furthermore, reasons that may influence the decision to admit low risk patients were analysed. In a prospective study 260 patients with CAP were included. Stratification in five risk classes according to the PSI was compared with parameters that are closely related to severity of CAR A significant difference in severity parameters, such as length of stay (P < 0.001) and simplified acute physiologic score and acute physiologic and chronic health evaluation II score (P < 0.001) was found between the five risk classes. Furthermore, a positive British Thoracic Society (BTS) rule and modified BTS rule score was significantly more prevalent in the higher risk classes (P < 0.001). The patient population had an average 30-day mortality of 10% and a mean Intensive Care Unit (ICU) admission rate of 8%. The mortality rate and ICU admission rate significantly differed between the five risk classes (P < 0.001), in which the highest ICU admission rate (40.9%) and the highest mortality percentage (40.9%) were both...Continue Reading

References

Oct 1, 1985·Critical Care Medicine·W A KnausJ E Zimmerman
Nov 1, 1984·Critical Care Medicine·J R Le GallD Villers
Nov 1, 1996·American Journal of Respiratory and Critical Care Medicine·A TorresJ Serra
Jan 23, 1997·The New England Journal of Medicine·M J FineW N Kapoor
Sep 15, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J G BartlettM J Fine
Jun 13, 2001·American Journal of Respiratory and Critical Care Medicine·M S NiedermanUNKNOWN American Thoracic Society
Jun 22, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B RosónF Gudiol
Aug 21, 2001·The European Respiratory Journal·R MenéndezM Perpiñá

❮ Previous
Next ❯

Citations

May 20, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M M van der EerdenW G Boersma
Jul 31, 2012·Critical Care : the Official Journal of the Critical Care Forum·Christophe MartiArnaud Perrier
Jun 19, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Patrick G P CharlesM Lindsay Grayson
Feb 3, 2009·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Huang-Pin WuDuen-Yau Chuang
Apr 24, 2007·European Journal of Internal Medicine·O EtzionF Schlaeffer
Nov 10, 2006·Médecine et maladies infectieuses·K Faure
Aug 26, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C FeldmanUNKNOWN International Pneumococcal Study Group
Jul 10, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·B RenaudUNKNOWN PNEUMOCOM study investigators
Jun 30, 2009·Annales de dermatologie et de vénéréologie·A DuparcP Modiano
Sep 25, 2014·Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine·Nr AdlerNd Friedman
May 15, 2007·Current Opinion in Infectious Diseases·Charles Feldman
Dec 14, 2006·Diseases of the Colon and Rectum·Chi Jun ParkJae Young Yoo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.